Island Pharmaceuticals Requests Trading Halt
Key points
- Pending announcement on agreement with US biodefence institutions
- Trading halt until 4 March 2026 or announcement release
- Maintaining orderly market in company's shares
Full summary
Island Pharmaceuticals Ltd (ASX: ILA) has requested a trading halt in its ordinary shares on the Australian Securities Exchange (ASX). The trading halt has been requested to allow the company to manage its disclosure obligations and maintain an orderly market in the trading of its shares. The trading halt will remain in place until the earlier of the open of trade on 4 March 2026 or the release of an announcement by the company. The announcement is expected to be in relation to a pending agreement with two strategic US-based biodefence institutions in connection with Island Pharmaceuticals' Galidesivir program.
Summary generated by a large language model. Please interpret with care.